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Abstract Rac1 is a Rho subfamily small GTPase which is highly expressed in epidermal keratinocytes. In mice the
significance of Rac1 for themaintenance of the epidermis has been controversial. In keratinocytes from human origin, the
role of Rac1 in the control of growth/differentiation is still obscure. In this study we used RNA interference to induce
specific inhibition of Rac1 expression in cultured human keratinocytes and analyzed the consequences on proliferation
and differentiation. We found that the autocrine proliferation of keratinocytes is unaltered by Rac1 silencing. However,
the suppression of Rac1 induced premature differentiation as revealed by the expression of markers (keratin 10,
involucrin), but the involvedmechanism is independent of the activity of p38mitogen-activatedprotein kinase. Rather,we
found that the effects of Rac1 silencing on keratinocytes differentiation are concomitant with negative regulation of the
Ser62/Thr58 phosphorylation on the transcription factor c-myc, amechanism known to control post-translational stability
of the c-myc protein. Thus, in growing human keratinocytes, Rac1 could impede the expression of premature
differentiation markers, probably by exerting positive control on c-myc activity and its binding to specific promoters.
J. Cell. Biochem. 9999: 1–8, 2007. ß 2007 Wiley-Liss, Inc.
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Keratinocytes, the major epidermal cell type,
proliferate and subsequently differentiate to
ensure the continual renewal of the protective
outermost layer of the skin. Any disturbance
in the balance between proliferation and dif-
ferentiation of keratinocytes can disrupt the
epidermal homeostasis and be the cause of skin
disorders [De Luca et al., 1994; Rao et al., 1996;
Iizuka et al., 2004]. Thus, understanding the
complex signaling mechanisms underlying the
physiological regulation of epidermal keratino-
cytes remains amajor challenge of skin biology.
Small Rho GTPases exert regulatory func-
tions on specific signaling events in keratino-
cytes. For instance, Rho function on distinct
transduction pathways to coordinate control on
cytoskeletal reorganizations and growth/differ-
entiation processes. The three best studied Rho
family members, Rho-A, -B, and -C have been
found to promote the establishment of epithelial
adhesion and simultaneously exert strict con-
trol on the epidermal differentiation process
[Braga et al., 1997; Grossi et al., 2005]. The
selective inhibition of Rho-A, -B, and -C by
bacterial toxin C3 causes premature differ-
entiation of growing keratinocytes from mouse
and human origins [Grossi et al., 2005].
Rac1 is another Rho family member express-
ed in epidermal keratinocytes. Similarly to the
closely related Rho-A, -B, and -C, Rac1 is involv-
ed in the dynamic changes during keratinocyte-
keratinocyte adhesion [Braga et al., 1997]. The
role of Rac1 in the control of keratinocytes has
been recently studied in vivo by two research
groups using mice models with restricted epi-
dermal deletion of Rac1 [Benitah et al., 2005;
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ß 2007 Wiley-Liss, Inc.
The institution at which the work was performed: Cell and
Tissue Laboratory, URPHYM,University of Namur (FUNDP),
B-5000 Namur, Belgium.
Grant sponsor: FRFC; Grant number: 2.4506.01.
*Correspondence to: Yves Poumay, CellQ1 and Tissue
Laboratory, URPHYM, University of Namur (FUNDP),
B-5000 Namur, Belgium. E-mail: yves.poumay@fundp.ac.be
Received 20 March 2007; Accepted 30 May 2007
DOI 10.1002/jcb.21455




Chrostek et al., 2006], however their results
were contradictory: according to Benitah et al.
[2005], epidermaldeletionofRac1 increasespro-
liferation of basal keratinocytes together with
an increased expression of the differentiation
marker keratin 10 (K10), mediated by an incre-
ased c-myc expression and activity; according to
Chrostek et al. [2006], keratinocyte-restricted
deletion of Rac1 gene in mutant mice does not
affect the normal proliferation rate of basal
keratinocytes, does not change the expression of
the differentiation markers, K10 and loricrin,
and does not alter c-myc expression. The likely
reasons for these contradictory results may be
due to the different genetic backgrounds of the
mice used in the two studies, or to the different
methods utilized for Rac1 deletion in skin.
In our present in vitro study, we applied the
technique of RNA interference (RNAi) in order
to achieve a specific Rac1 protein suppression
[Wang and Zheng, 2007] in cultured normal
human adult keratinocytes (NHAK). Then, we
studied the effects of Rac1 silencing on the rate
of DNA synthesis, on the expression of differ-
entiation markers (K10 and involucrin) and on
the expression andphosphorylation of the c-myc
transcription factor. Our results indicate that
Rac1 silencing induces premature differentia-
tion without affecting the proliferation of the
cultured human keratinocytes. Concomitantly,
we report that the suppression of Rac1 does not
alter c-myc expression but its phosphorylation
at Ser62/Thr58 involved in posttranslational
control of c-myc protein [Sears et al., 2000],
suggesting that Rac1 negatively controls kera-




Primary antibodies were purchased from
the following manufacturers: mouse anti-Rac1
(23A8) from Upstate cell signaling solutions,
The Netherlands; mouse anti-RhoA (sc-418)
from Santa Cruz Biotechnology, CA; mouse
anti-Cdc42 from BD Transduction Laborato-
ries, Belgium; mouse anti-Human Cytokeratin
10, Dako Cytomation, Denmark; mouse anti-
Human Cytokeratin 14, Novocastra laborato-
ries Ltd, UK; rabbit anti-Human Involucrin,
Harbor Bio-Products,MA;mouse anti-phospho-
ERK1/2 (Thr202-Tyr204), rabbit anti-phospho-
p38 (Thr180-Tyr182), and rabbit anti-p38 MAP
Kinase from Cell Signaling; Danvers, MA;
rabbit anti-phospho- JNK1/2 (Thr183-Tyr185)
from Biosource International, Inc.; mouse anti
c-myc (Invitrogen Life Technologies); rabbit
anti-phospho-c-Myc (Thr58/Ser62) from Cell
Signaling; mouse anti-b-actin (AC-15) from
Sigma, St. Louis,MI. Secondary antibodies were
goat anti-mouse-HRP and goat anti-rabbit-
HRP, both from Dako Cytomation. Methyl-
[3H]-thymidine is from MP Biomedicals, Inc.,
Irvine, CA.
Cell Cultures
Normal human adult keratinocytes (NHAK)
were isolated from skin explants obtained
during abdominal plastic surgery from 25 to
45 years old healthy donors as described
[Poumay et al., 1999]. Third and fourth pas-
sages keratinocytes were seeded at density
7 103 cells/cm2 and were maintained in
serum-free EpiLifeMedium (Cascade Biologics,
Inc., UK) with added growth supplement
(Human Keratinocytes Growth Supplement,
Cascade Biologics, Inc.) and antibiotics. The
cells were incubated at 378C and 5% CO2 till
reaching 50–60% confluence, then switched to
autocrine growth conditions by excluding the
growth factors from the medium. The cells
were fed every other day with fresh medium.
All the experiments were performed on cells
cultured under autocrine growth conditions.
siRNA Transfection
21-nucleotide long siRNAs were chemically
synthesized, desalted, deprotected, and purified
by polyacrylamide-gel electrophoresis (PAGE)
(Eurogentec, Belgium). The 50-GAUAAAGA-
CACGAUCGAGA-30 and 50-UCUCGAUCGU-
GUCUUUAUC-30 oligoribonucleotides were
used to inhibit Rac1. The sense and antisense
oligoribonucleotides were annealed at concen-
tration 100 mM in 50 mM NaCl, 1 mM EDTA,
10 mM Tris-HCl, pH 7.5. As a control, we used
the siRNA negative control, a perfectly unique
sequence which does not match to any sequen-
ce in the human genome, recommended by the
manufacturer (cat #OR-0030-NEG05, Eurogen-
tec). Transient transfections were carried out
using Oligofectamine (Invitrogen Life technol-
ogies) and manufacturer’s instructions. The
cells were split in 24 well plates 1 day before
transfection. On the next day when reaching
50% of culture confluence, keratinocytes were
2 Nikolova et al.
Author Proof
A
transfected in medium without antibiotics with
Rac1-specific siRNA or siRNA control duplex at
100 nM final concentration. The silencing of
Rac1 was assayed 3 days after the transfection
by at least three independent experiments.
DNA Synthesis Assay: [3H] Thymidine
Incorporation
Keratinocytes were split in 24 well plates, at
a density which allows cells to reach 50% of
confluence on the next day, then the trans-
fection was performed as above. Forty eight
hours later, the cells were switched to autocrine
growth conditions for 18–20 h. [3H]-Thymidine
at final concentration 1 mCi/ml was added to
the culture medium 4 h before harvesting and
analyzing the cells. Briefly, cells were washed,
then treated successively with ice-cold PBS,
10%TCA (twice) and 5%TCA (three times) and
lysed in 500 ml 1 N NaOH and 0.1% SDS. The
rate of proliferation was measured as the radio-
activity incorporated into DNA using a Beck-
man Liquid Scintillation Counter (Beckman
Coulter, Inc., Fullerton, CA).
Western Blot Analyses
For Western blotting, the cells transfected
with Rac1-specific siRNA or siRNA control
duplex were washed in ice-cold PBS, harvested
and solubilized in lysis buffer (20 mM Tris-HCl
(pH 6.8), 2% SDS, 10% saccharose, 50 mM
ditiothreitol, 0.1% bromophenol blue). Equal
amounts of total protein were separated on
7.5%, 10%, or 12.5% polyacrylamide gels
depending on the effective range of separation
of the gel and the respectivemolecularweight of
the analysed proteins (7.5% gel for involucrin—
68 kDa; 10% gel for total and phospho c myc—
64 kDa, K10—56.5 kDa, K14—50 kDa, phos-
pho-ERK 1/2—42/44 kDa; phospho JNK1/2—
46/54 kDa; total and phospho p38—43 kDa; beta
actin—42 kDa; 12.5% gel for RhoA—24 kDa;
Cdc42—22 kDa, Rac1—21 kDa). The proteins
were transferred to polyvinylidene difluoride
(PVDF) membranes (Millipore, Bedford, MA)
and immunoblotting analyses with specific
primary antibodies and peroxidase-conjugated
secondary antibodies diluted 1:1,000 were car-
ried out using the ECL technique (Roche
Molecular Biochemicals, Indianapolis, IN).
To confirm equivalent protein loading, blots
were probed with an antibody to b-actin or to
total p38.
Real-Time RT-PCR Analyses
Total RNA was isolated from the transfected
cells by applying RNeasy Mini Kit (Qiagen,
France). One microgram of total RNA was used
for cDNA preparation by using SuperScriptTM
II RNase H Reverse Transcriptase (Invitrogen
Life Technologies) following themanufacturer’s
protocol. After cDNA preparation, 1 ng was
mixedwith 10 ml Power SybrGreenPCRMaster
Mix (Applied Biosystems) and specific oligonu-
cleotide primers (Sigma–Aldrich,UK), at 300nM
final concentration, for Rac1 (senseGCTAAGG-
AGATTGGTGCTGTAAAA, antisense CTGCT-
CGGATCGCTTCGT), K14 (sense CGATGGC-
AAGGTGGTGTC, antisense GGGTGAAGCA-
GGGTCCAG), K10 (sense AATCAGATTCT-
CAACCTAACAAC, antisense CTCATCCAGC-
ACCCTACG), and involucrin (sense TGAAA-
CAGCCAACTCCAC, antisense TTCCTCTT-
GCTTTGATGGG) for real-time quantitative
PCR analysis. The results are expressed as
specific relative mRNA levels measured in
regard of the house-keeping gene 36B4 mRNA
expression. For the measurement of 36B4
expression, the following specific oligoribonu-




siRNA—Mediated Specific Reduction of
Rac1 Protein Level in Cultured Normal
Human Keratinocytes
Wishing to investigate the functions of Rac1
in epidermal keratinocytes, we decided to
evaluate the consequences induced in cultured
NHAK by a selective inhibition of Rac1 expres-
sion. A specific Rac1 siRNA (hereafter desig-
nated as siRac1) was introduced into cultured
human epidermal keratinocytes by carrying out
a transient transfection mediated by oligofect-
amine. This transfection produced an efficient
Rac1 protein suppression in epidermal kerati-
nocytes (Fig. 1A) when compared with the level
of Rac1 detected after the same transfection
performed with control siRNA (hereafter des-
ignated as siRNA control). Furthermore, our
siRac1 duplex showed highly specific inhibitory
action on Rac1 protein expression without
affecting other closely related Rho subfamily
members: Cdc42 and RhoA (Fig. 1A). When
observed by phase-contrast microscopy 3 days
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after transfection, keratinocytes transfected
with siRac1 revealed in several cells an elon-
gated shape phenotype (Fig. 1B, arrows) less
frequently observed in keratinocytes trans-
fected with siRNA control (Fig. 1B), suggesting
that Rac1 is involved in normal cell shape in
keratinocytes.
Rac1 Silencing Does not Alter DNA Synthesis in
Growing Cultured Keratinocytes
In order to detect whether Rac1 is playing a
role in the control of NHAK proliferation, we
performed transient transfectionwith siRac1 or
siRNA control. Then, 3 days later, the cells were
allowed to incorporate radioactive [3H]-thymi-
dine. The amount of incorporated [3H]-thymi-
dine determined per mg of protein revealed no
significant change (9–11% inhibition) in the
rate of keratinocytes DNA-synthesis after
siRNA-mediated Rac1 silencing, compared to
the control (Fig. 2).
Rac1 Silencing Influences the Expression Level of
Differentiation Markers, but not the
Expression of a Basal Marker
We applied siRNA specific inhibition to
achieve selective Rac1 suppression in keratino-
cytes, then we examined the consequences on
the expression of basal (K14) anddifferentiation
(K10 and involucrin) markers. Both real time
RT-PCR and Western blot analyses confirmed
upregulation of differentiation markers at
mRNA and protein levels after Rac1 silencing
compared to the siRNA control (Fig. 3A,B).
Concomitantly, the expression of the basal K14
marker remained unchanged.
Fig. 1. Rac1 protein expression is efficiently suppressed
by specific small interfering RNA in NHAK and is accompanied
by an alteredmorphology in several cells.A: A test for specificity
and efficiency of siRac1 was fulfilled by Western blot analyses.
NHAK were transfected with siRac1 or siRNA control as
described in Materials and Methods. Three days after trans-
fection, treated cells were harvested, their total protein was
extracted and subjected to Western blot analyses with primary
antibodies specific for Rac1, Cdc42 and RhoA. Beta-actin levels
were determined as a protein loading control. Representative
data of three independent experiments. B: Rac1-specific small
interfering RNA in parallel with non-specific control RNA were
introduced in NHAK by carrying out a transient transfection as
it was described in Materials and Methods. Three days after
transfection, NHAK were screened by phase-contrast micro-
scopy in order to detect alteration due to siRNA-mediated Rac1
silencing.Arrowspoint elongated shape keratinocytes frequently
observed after siRac1 treatment. Scale bars, 100 mm. Fig. 2. The inhibition of Rac1 expression has no significant
effect on the rate of DNA synthesis in NHAK. NHAK were
transiently transfected with siRac1 or siRNA control as it was
described in Materials and Methods. Forty eight hours after the
transfection, the cells were switched to autocrine growth
conditions for 18–20 h. Four hours before cell analysis, 1 mCi/
ml of [3H]-thymidine was added to the culture medium. The rate
of cell proliferation was measured by determining the radio-
activity incorporated into DNA. Data are mean SEM of three
independent experiments.
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Rac1 Silencing and its Consecutive Effects on
Keratinocyte Differentiation Are Not
Accompanied by Any Change in Phosphorylation
of Mitogen-Activated Protein Kinase (MAPK)
Family Members—ERK1/2, p38, JNK1/2
Since functional interactions between Rac1
and MAPK family members, ERK1/2, p38, and
JNK1/2, have been reported in several systems
different than keratinocytes [Coso et al., 1995;
Minden et al., 1995; Frost et al., 1997], we
examined the consequences of Rac1 silencing on
the activation of these three signaling pathways
in NHAK. For this purpose, protein extracts of
keratinocytes treated with siRac1 or siRNA
control were analyzed by Western blotting
using specific antibodies against phospho
ERK1/2, against phospho JNK1/2, or against
phospho p38 and total p38 (Fig. 4): the inhibited
Rac1 expression in keratinocytes does not influ-
ence the level of neither of the three phospho
MAPKs, suggesting no interaction between
Rac1 and the MAPKs in these conditions.
In Human Keratinocytes, Rac1 Silencing Impedes
Ser62/Thr58 Phosphorylation in c-myc
Three days after transient transfection with
siRac1, or siRNA control, NHAKwere analyzed
for both c-myc expression and phosphorylation
on residues Ser62 and Thr58 by Western
blotting and specific antibodies. The silencing
of Rac1 does not alter expression of c-myc but
induces a decreased Ser62/Thr58 phosphoryla-
tion (Fig. 5), suggesting that Rac1 is involved
directly or indirectly in the regulation of this
phosphorylation known to control myc stability
and accumulation in several different cell types
[Sears et al., 2000; Vervoorts et al., 2006].
DISCUSSION
Several recent studies have suggested that
Rho family proteins, including Rac1, play cru-
cial roles in regulation of mouse keratinocyte’s
Fig. 3. Rac1 silencing induces the expression of differentiation
markers as detected both at mRNA and protein levels. NHAK
were transiently transfected with siRac1 or siRNA control as
described in Materials and Methods. Three days after cell
transfection, the expression of proliferative marker, K14 and
differentiation markers, K10 and involucrin, was analyzed at
mRNA (A) and protein (B) levels. For real time PCR analyses, total
RNA was extracted from transfected cells and used for cDNA
preparation. By the use of specific oligonucleotide primers, the
relative levels of mRNA of Rac1, K14, K10, and involucrin were
determined and expressed after normalization with the house-
keeping gene 36B4 mRNA expression (A). For the Western blot
analyses whole protein extracts from transfected cells were
probed after electrophoresis and transfer with specific primary
antibodies against Rac1, K14, K10 or involucrin (B). Beta actin
levels were analyzed as loading control. The results are
representative of three independent experiments.
Fig. 4. Rac1 silencing does not affect the phosphorylation of
MAPKs members—ERK1/2, p38, and JNK1/2 in NHAK. NHAK
were transiently transfected with siRac1 or siRNA control as it
was described in Materials and Methods. Three days after the
transfection, the cells were harvested and whole protein extracts
were analyzed by Western blotting with specific primary
antibodies against Rac1, phospho-ERK1/2, phospho- and total-
p38, or phospho-JNK1/2. Total p38 protein levels confirm the
equivalent protein loading on the gel. Two independent experi-
ments confirmed the results.
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botulinum that selectively inhibits RhoA, -B,
and -C but not Rac1 and found that this
treatment does not affect the proliferative
activity of the cells, but is sufficient to induce
expression of differentiation markers (K1, K10,
involucrin, filaggrin). Since a selective and
potent inhibitor for Rac1 was not available,
Benitah et al. [2005] and Chrostek et al. [2006]
independently generated two different mice
mutants with restricted deletion of the Rac1
gene in epidermis. The two studies however
reported results with strikingly contrasting
observations, probably depending on the strain
(genetic background) of the analyzed mice or
on the method used for Rac1 disruption. As
Chrostek et al. [2006] discussed in their study,
one example of such a discrepancy has already
been reported for differences in skin, brain and
lung phenotypes in EGF receptor-deficient
mice, depending on the strain of the analyzed
animals [Sibilia et al., 1998]. According to
Benitah et al. [2005], epidermal deletion of
Rac1 causes increased proliferation of basal
keratinocytes, followed by increased expression
of the differentiation marker K10, mediated by
induced c-myc expression and activity. Con-
versely according to Chrostek et al. [2006],
keratinocyte-restricted deletion of rac1 gene in
mutant mice does not affect the normal prolif-
eration rate of basal keratinocytes, does not
change the expression of differentiation-specific
K10 and loricrin and does not alter c-myc
expression.
In our in vitro study with human keratino-
cytes, we found that Rac1 silencing does not
significantly influence the proliferative activity
of the cells. Although Benitah et al. [2005]
reported an increase of basal keratinocyte
proliferation and some thickening of the Rac1
deficient epidermis, Chrostek et al. [2006] found
no effect on epidermal proliferation in their
Rac1-null mice.
Again in our in vitro study, we report that
Rac1 suppression induces premature expres-
sion of the two differentiation makers we
analyzed, K10 and involucrin. This is in con-
trast with the lack of effect on differentiation
observed by Chrostek et al. [2006] in their Rac1-
deficient mice mutant. Thus, our results sug-
gest that in human cultured keratinocytes Rac1
exerts negative control on the epidermal differ-
entiation without influencing cell proliferation.
Our results demonstrate similar effects of Rac1
inhibitionwith those established byGrossi et al.
[2005] after inhibition of Rho A, B, and C.
The p38 MAPK family member is known to
promote keratinocyte differentiation and apo-
ptosis [Eckert et al., 2002]. Thus, we have
investigated whether premature induction of
differentiation markers after suppression of
Rac1 could be mediated by activation of p38.
However, our resultshave shownno influence of
Rac1 suppression on the activation of p38, or on
the activation of neither of the two other MAPK
family members, ERK1/2 and JNK1/2. This
concurs with themousemodel of Chrostek et al.
[2006]where epidermal deletion ofRac1 neither
affects p38 or JNK activation.
Another discrepancy between the two mice
models of Benitah et al. [2005] and Chrostek
Fig. 5. Rac1 silencing inhibits Ser62/Thr58 phosphorylation of
c-myc in NHAK. NHAKwere transiently transfected with siRac1
or siRNA control (see Materials and Methods). Three days after
transfection, the treated keratinocytes were harvested, their total
protein content was extracted, and then analyzed by Western
blotting with specific primary antibodies against Rac1, total
c-myc and Ser62/Thr58 phosphorylated c-myc. Beta-actin was
used as a loading control. Two independent experiments
confirmed the results.
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et al. [2006] concerns the effect of Rac1 deletion
on the transcription factor c-myc. According
to Benitah’s study [2005], Rac1 sustains basal
proliferation in keratinocytes through negative
regulation of c-myc expression and activity.
However according to Chrostek et al. [2006],
keratinocytes-restricted Rac1 deletion does not
influence c-myc expression. In our present
study, we explored in cultured human kerati-
nocytes the consequences of Rac1 silencing on
c-myc expression and c-myc phosphorylation
at its two N-terminal phosphorylation sites,
Ser62/Thr58, and found that Rac1 suppression
does not alter c-myc expression, but negatively
regulates c-myc phosphorylation. Ser62/Thr58
phosphorylation has been previously found to
be critical for determining the stability of c-myc.
Phosphorylation of Ser62 is involved in stabiliz-
ing c-myc by increased half-life and activity.
The phosphorylation of Thr58 depends on the
prior phosphorylation of Ser62 [Vervoorts et al.,
2006]. Thr58 phosphorylation promotes c-myc
degradation through the ubiquitin/proteasome
system, controlling the duration of c-myc activ-
ity. Ser62/Thr58 phosphorylation emerges as
an important mechanism for posttranslational
control of c-myc protein levels and activity
[Sears et al., 2000]. In fibroblasts and in cell
types different than keratinocytes, c-myc is
detected at high levels of Ser62/Thr58 phos-
phorylation after growth stimulation, when
c-myc protein plays critical role in promoting
G1/S progression of the cell cycle [Berns et al.,
1997; Liu et al., 2004; Murphy et al., 2004]. In
contrast, in epidermal keratinocytes, the func-
tions of c-myc have been reported to be not so
simple and even contradictory. From one side,
Benitah et al. [2005] and Murphy et al. [2005]
found that c-myc activity promotes keratinocyte
differentiation and keratinocytes stem cells
proliferation is sustained by c-myc suppression.
Conversely, Zanet et al. [2005] established in
epidermal Myc knock-out (KO) mutant mice
that a lack of c-myc causes premature differ-
entiation—the markers of early terminal dif-
ferentiation, K1 and K10 being extensively
expressed in the basal layer of KO epidermis,
where also later differentiation markers, invo-
lucrin and filaggrin, were also detected. Inter-
estingly, keratinocytes of the basal layer
continued toproliferatenormally.A thirdbunch
of data argues about pro-proliferative functions
of c-myc in keratinocytes. It has been found that
the inhibition of CaMK and MAPK by their
selective pharmacological inhibitors (KN-62
and PD98059, respectively) inhibits c-myc
activity and human keratinocyte proliferation
[Praskova et al., 2002]. c-myc appears to gather
signals from different transduction pathways
which probably modulate its activity in differ-
entways, explaining the observed contradictory
effects of c-myc in epidermal keratinocytes.
In our study, we further observed that Rac1
suppression inhibits c-myc phosphorylation on
Ser62/Thr58. This inhibition is concomitant
with premature expression of differentiation
markers but do not significantly influence the
proliferative activity of thekeratinocytes. These
results concur with those of Zanet et al. [2005]
who found that c-myc exhibits a negative effect
of on the expression of differentiation markers
in normal mouse epidermis but lacks any effect
on basal keratinocytes proliferation.
Taken together, our results demonstrate that
in regard of growth/differentiation in human
keratinocytes, Rac1 exerts the same regulatory
functions as was established for the other Rho
family members, Rho-A, -B, and -C. Rho and
Rac1 exert negative control on keratinocyte
differentiation. Because Grossi et al. [2005]
found in their study that Rho-A, -B, and -C
exert the negative control on keratinocytes
differentiation through activation of their effec-
tor protein, CRIK kinase, the involvement of
CRIK kinase in the control exerted by Rac1 on
keratinocyte differentiation should now be
investigated, especially since an active mutant
form of Rac1 has been found to increase CRIK
kinase activity [DiCunto et al., 1998]. Finally, it
must be noticed that Grossi et al. [2005] have
proposed that Rho/CRIK pathway is of signifi-
cance in vivo under conditions such as wound
healing, when the normal differentiation proc-
ess is arrested and/or reversed. Hence, the very
recently illustrated role of Rac1 in epidermal
wound healing [Tscharntke et al., 2007] and the
significant impairment of epidermal hyperpro-
liferation during wound healing in absence of
Myc [Zanet et al., 2005] concur to suggest that
the functional interaction between Rac1 and
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